TRK-750
/ Toray
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 15, 2022
A Study to Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)
(clinicaltrials.gov)
- P2 | N=0 | Withdrawn | Sponsor: Toray Industries, Inc | N=240 ➔ 0 | Not yet recruiting ➔ Withdrawn
Enrollment change • Trial withdrawal • Colorectal Cancer • Gastrointestinal Cancer • Oncology • Pain • Solid Tumor
March 07, 2020
A study to investigate the safety and efficacy of TRK-750 for thetreatment of patients with CIPN
(clinicaltrialsregister.eu)
- P2; N=120; Ongoing; Sponsor: Toray Industries, Inc.
Clinical • New P2 trial
February 25, 2020
A Study to Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)
(clinicaltrials.gov)
- P2; N=240; Not yet recruiting; Sponsor: Toray Industries, Inc
Clinical • New P2 trial
1 to 3
Of
3
Go to page
1